Alert detail
FDA Approval: ARGATROBAN IN DEXTROSE (ARGATROBAN) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA201743Specialty: HematologyAdded: 6/9/2026Effective: 2011-05-09billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.